E5090, a novel orally bioavailable inhibitor of IL-1 generation, has antiinflammatory properties. References: Fukumura D, Miura S, Kurose I, Higuchi H, Suzuki H, Ebinuma H, Han JY, Watanabe N, Wakabayashi G, Kitajima M, Ishii H. IL-1 is an important mediator for microcirculatory changes in endotoxin-induced intestinal mucosal damage. Dig Dis Sci. 1996 Dec;41(12):2482-92. PubMed PMID: 9011462.

纯度：≥98%

CAS：131420-91-2